Navigation Links
New discovery could aid development of elusive bovine mastitis vaccine

Researchers have discovered components of the bovine mastitis-causing bacterium, Streptococcus uberis that play a key role in the disease. This discovery could lead the way to finally developing a vaccine for this endemic disease, which costs UK farmers alone nearly 200M per year, requires the large scale use of antibiotics, causes pain to cows and dramatically reduces milk yield. A solution to this problem will be an important contribution to the future security of our food supply in the UK. The research is due to be published in Veterinary Research.

BBSRC-funded researcher Professor James Leigh and his team from The University of Nottingham, along with colleagues at the Institute for Animal Health and the University of Oxford, have discovered that Streptococcus uberis a major cause of bovine mastitis uses the enzyme SrtA to anchor at its surface the proteins required for it to cause disease. They have also identified the individual anchored proteins that are required for the bacterium to withstand the responses within the udder that are trying to eliminate it.

Professor Leigh said: "What's really exciting about this is that we've discovered elements of one of the main culprits in bovine mastitis that could actually lead to a vaccine in the future.

"By identifying which components of the bacteria play a role in causing the disease, we can see exactly where to hit it with a vaccine to stop it ever becoming a problem."

At present bovine mastitis requires the large scale use of antibiotics to treat the disease and we know that this may lead to problems of antibiotic resistance down the line. Unfortunately, apart from good husbandry, there is little that can be done to prevent the disease at present.

The team is funded by the Biotechnology and Biological Sciences Research Council (BBSRC) under a scheme that aims to find sustainable ways to reduce the impact of endemic diseases of farm animals on the economy of UK farming industry and the welfare of animals that are kept for meat, eggs and dairy products. This is the BBSRC Combating Endemic Diseases of Farmed Animals for Sustainability (CEDFAS) initiative.

Professor Douglas Kell, BBSRC Chief Executive said: "To feed a growing global population we need to increase food production by 70% by 2050. We have to do this in a sustainable and ethical way and ensure that the UK farming industry remains strong. Endemic diseases of farm animals are extremely costly and cause significant welfare issues. This development is a welcome step towards preventing the suffering and losses associated with bovine mastitis."


Contact: Nancy Mendoza
Biotechnology and Biological Sciences Research Council

Related biology news :

1. Discovery may help defang viruses
2. Stomach stem cell discovery could bring cancer insights
3. Symposium marks 30th anniversary of discovery of third domain of life
4. Emory paleontologist reports discovery of carnivorous dinosaur tracks in Australia
5. Natural product discovery by Cleveland medical researchers blocks tissue destruction
6. Researchers discovery may lead to hypertension treatment
7. Yale discovery suggests protein may play a role in severe asthma
8. Galapagos and Cystic Fibrosis Foundation Therapeutics announce drug discovery collaboration
9. Profound immune system discovery opens door to halting destruction of lupus
10. Scripps Research discovery leads to broad potential applications in CovX-Pfizer deal
11. New discovery could reduce the health risk of high-fat foods
Post Your Comments:
(Date:11/19/2015)... NEW YORK , Nov. 19, 2015  Although ... the market is dominated by a few companies, according ... Qiagen. These companies own 51% of the market share of ... report, The World Market for Molecular Diagnostic ... "The market is still controlled by one ...
(Date:11/17/2015)... -- Paris from 17 th ... Paris from 17 th until 19 th ... has invented the first combined scanner in the world which ... surface. Until now two different scanners were required: one for ... on the same surface. This innovation is an ideal ...
(Date:11/17/2015)... , Nov. 17, 2015 Pressure BioSciences, ... in the development and sale of broadly enabling, pressure ... life sciences industry, today announced it has received gross ... $5 million Private Placement (the "Offering"), increasing the total ...  One or more additional closings are expected in the ...
Breaking Biology News(10 mins):
(Date:11/27/2015)... Kingdom , Nov. 27, 2015 /PRNewswire/--  Mallinckrodt plc ... company, announced today that it has closed the sale ... business to Guerbet (GBT- NYSE Euronext) in a transaction ... encompassed four manufacturing facilities and a total of approximately ... in the St. Louis area. ...
(Date:11/26/2015)... , November 26, 2015 ... --> Accutest Research Laboratories, a ... Research Organization (CRO), has formed a ... Center - Temple Health for joint ... ,     (Photo: ) , ...
(Date:11/25/2015)... Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) ... a stockholder rights plan (Rights Plan) in an effort ... carryforwards (NOLs) under Section 382 of the Internal Revenue ... PharmAthene,s use of its NOLs could be substantially ... defined in Section 382 of the Code. In general, ...
(Date:11/25/2015)... HOLLISTON, Mass. , Nov. 25, 2015 ... a biotechnology company developing bioengineered organ implants for life-threatening ... will present at the LD Micro "Main Event" investor ... PT. The presentation will be webcast live and posted ... also be available at the conference for one-on-one meetings ...
Breaking Biology Technology: